CTLA4 and neoplasm: For example, cytotoxic T lymphocyte antigen-4 (CTLA-4) is an immune checkpoint molecule predominantly expressed on T-cells, and CTLA-4 blockade combined with radiotherapy significantly modulates the TCR repertoire of tumor-infiltrating T-cells [23].